Acasti Pharma Inc. Receives Health Canada Clearance for an Open-Label Phase II Hypertriglyceridemia Trial Oct 17, 2011
Acasti Pharma Announces the Initiation of Phase II Clinical Study of CaPre(R) for the Treatment of Hypertriglyceridemia Oct 4, 2011
